8-K: Purple Innovation Q3: Improved Net Loss, Positive Adjusted EBITDA

Purple Innovation reports third quarter 2025 results, showing an improved net loss and positive adjusted EBITDA, driven by product momentum and strategic partnerships.

Summary

• Net revenue for Q3 2025 was $118.8 million, a slight increase compared to $118.6 million in Q3 2024.
• Gross profit for Q3 2025 increased to $50.9 million, or 42.8% of net revenue, up from $35.2 million or 29.7% in the prior year period.
• Adjusted gross margin expanded by 230 basis points to 42.8% in Q3 2025, compared to 40.5% in the year-prior period.
• Operating expenses were $63.0 million, a 23.2% decrease from $82.0 million in Q3 2024, primarily due to lower restructuring and impairment charges.
• Net loss attributable to Purple Innovation, Inc. for Q3 2025 was $11.7 million, a significant improvement from a $39.2 million loss in the prior year.
• Adjusted EBITDA for Q3 2025 was positive $0.2 million, an improvement from $(6.4) million in Q3 2024.
• Cash and cash equivalents stood at $32.4 million as of September 30, 2025, up from $29.0 million as of December 31, 2024.
• Net inventories totaled $65.8 million as of September 30, 2025, an increase of 9.8% compared to September 30, 2024, and 15.7% compared to December 31, 2024.
• The company is maintaining its full-year 2025 guidance, projecting revenue of $465 million to $485 million and adjusted EBITDA of breakeven to $10 million.

Sentiment

Score: 7

Explanation: The company demonstrated significant operational improvements, achieving positive adjusted EBITDA and a substantially reduced net loss, while maintaining its full-year guidance. This indicates successful execution of its restructuring and strategic initiatives. However, the continued GAAP net loss, increased related party debt, and negative stockholders' equity present ongoing financial challenges that temper overall sentiment.

Positives

• Achieved an improved net loss of $11.7 million in Q3 2025, down from $39.2 million in Q3 2024.
• Reported positive adjusted EBITDA of $0.2 million in Q3 2025, a significant improvement from $(6.4) million in Q3 2024.
• Gross profit increased to 42.8% of net revenue in Q3 2025, up from 29.7% in the prior year.
• Adjusted gross margin expanded by 230 basis points to 42.8% in Q3 2025.
• Operating expenses decreased by 23.2% year-over-year, driven by reduced restructuring and impairment charges.
• Net revenue showed a slight increase, marking an important inflection point in sales trends after consecutive quarters of year-over-year declines.
• The Rejuvenate 2.0 product launch and the expansion of the Mattress Firm partnership are driving continued product and brand momentum.
• The restructuring program launched one year ago is now complete, making the company leaner and more agile.
• Cash and cash equivalents increased to $32.4 million as of September 30, 2025, from $29.0 million at year-end 2024.

Negatives

• The company still reported a net loss of $11.7 million for the third quarter.
• Experienced softer performance in the e-commerce channel, partially offsetting strength in showroom and wholesale channels.
• Tariff headwinds were noted as impacting gross margin, although sequential improvement was achieved.
• Net inventories increased by 9.8% year-over-year and 15.7% compared to December 31, 2024, reaching $65.8 million.
• Related party debt significantly increased to $102.889 million as of September 30, 2025, from $55.394 million as of December 31, 2024.
• Total stockholders' equity (deficit) shifted from a positive $20.198 million at December 31, 2024, to a negative $(26.939) million at September 30, 2025.

Risks

• Changes in economic, financial, and end-market conditions in the markets where the company operates.
• Fluctuations in raw material prices and cost of labor.
• The financial condition of customers and suppliers.
• Competitive pressures, including the need for technology improvement, successful new product development, and introduction.
• Changes in consumer demand, including pullbacks in consumer spending.
• Disruptions to manufacturing processes.
• Other risk factors outlined in the Annual Report on Form 10-K filed with the SEC on March 14, 2025, and in other SEC filings.

Future Outlook

The company is maintaining its 2025 guidance, projecting full-year revenue of $465 million to $485 million and adjusted EBITDA of breakeven to $10 million. This outlook is supported by the strong performance of the Rejuvenate 2.0 mattress launch and the successful rollout of the Mattress Firm partnership. The company expects to deliver positive adjusted EBITDA for the full year.

Management Comments

• "Our third quarter results reflect the continued progress we’re making in strengthening Purple’s foundation and positioning the company for sustainable, profitable growth." Rob DeMartini, CEO.
• "We delivered results in line with expectations, achieving an improved net loss and positive adjusted EBITDA and a sequential improvement in gross margin despite tariff headwinds." Rob DeMartini, CEO.
• "One year after launching our restructuring program, Purple is a leaner, more agile company that is now firmly focused on scaling for growth." Rob DeMartini, CEO.
• "The success of Rejuvenate 2.0, the ongoing expansion of our Mattress Firm partnership, and strong showroom performance all underscore the power of our innovation and our brand momentum, marking an important inflection point in sales trends after consecutive quarters of year-over-year declines." Rob DeMartini, CEO.
• "We are entering the final months of the year with confidence, executing against our Path to Premium Sleep strategy and remaining on track to deliver positive adjusted EBITDA for the full year." Rob DeMartini, CEO.

Industry Context

Purple Innovation's focus on its 'Path to Premium Sleep' strategy, evidenced by the success of Rejuvenate 2.0 and the expanded Mattress Firm partnership, aligns with a broader industry trend towards differentiated, higher-margin products in the bedding sector. The reported strength in showroom and wholesale channels, alongside softer e-commerce performance, suggests a potential shift in consumer purchasing preferences or increased competition in online retail, highlighting the importance of a robust omnichannel strategy. The company's ability to achieve positive adjusted EBITDA and improve its net loss indicates effective execution within a competitive market, particularly as it leverages innovation and strategic retail partnerships to drive growth in the premium segment.

Related Party Transactions

• Proceeds from related party loan of $39.0 million for the nine months ended September 30, 2025.
• Related party debt increased from $55.394 million as of December 31, 2024, to $102.889 million as of September 30, 2025.

Stakeholder Impact

• Shareholders: The improved profitability metrics (reduced net loss, positive adjusted EBITDA) and maintained guidance could be viewed positively, suggesting the turnaround is progressing. However, the increase in related party debt and negative stockholders' equity may raise concerns about long-term financial structure.
• Customers: The success of new product lines like Rejuvenate 2.0 and the expanded partnership with Mattress Firm indicate a broader availability of products and continued innovation, potentially enhancing customer choice and satisfaction.
• Employees: The completion of the restructuring program suggests a more stable operational environment, although it implies previous workforce adjustments.
• Creditors: The significant increase in related party debt highlights a reliance on specific financing sources, which could be a factor in assessing the company's credit profile.

Next Steps

• Continue executing against the 'Path to Premium Sleep' strategy.
• Deliver positive adjusted EBITDA for the full year 2025.
• Host a live conference call on November 4, 2025, at 4:30 p.m. Eastern Time to discuss financial results.

Key Dates

Recommendation

Purple Innovation has demonstrated commendable progress in its turnaround, achieving positive adjusted EBITDA and significantly narrowing its net loss, while also maintaining its full-year guidance. This indicates effective strategic execution and operational discipline. However, the company still reports a GAAP net loss, and the substantial increase in related party debt, coupled with a shift to negative stockholders' equity, presents ongoing financial structural concerns. While the momentum is positive, these underlying financial challenges warrant a cautious approach. A 'hold' recommendation allows investors to observe sustained profitability and a strengthening balance sheet before considering a more aggressive stance.

Keywords

Purple Innovation, PRPL, Q3 2025, financial results, adjusted EBITDA, net loss, revenue, gross margin, Mattress Firm, Rejuvenate 2.0, sleep technology, mattress, e-commerce, wholesale, corporate restructuring